Novartis announced FDA approved Kisqali® (ribociclib), a new drug to treat early-stages of breast cancer. Ekta Batra dwells into more details reagrding the drug. #breastcancer #FDA #novartis #drug #cancer #cnbctv18digital | CNBC-TV18
0:55
FacebookCNBC-TV18
Novartis announced FDA approved Kisqali® (ribociclib), a new drug to treat early-stages of breast cancer. Ekta Batra dwells into more details reagrding the drug. #breastcancer
CNBC-TV18. . Novartis announced FDA approved Kisqali® (ribociclib), a new drug to treat early-stages of breast cancer. Ekta Batra dwells into more details reagrding the drug. #breastcancer #FDA #novartis #drug #cancer #cnbctv18digital
432 viewsSep 18, 2024
Related Products
Astex Kisqali
Bivirkningsboks Kisqali
Femara Tablete I Kisqali
#Ribociclib Uses
Ribociclib Kisqali Medication uses, side effects & Lowest cost
Ribociclib Kisqali Medication uses, side effects & Lowest cost
rumble.comJun 11, 2024
In this video, I discuss ribociclib and abemaciclib in early stage HR /HER2- breast cancer. Both are CDK 4/6 inhibitors which interfere with the cell cycle and are used in combination with endocrine therapy to decrease the risk of recurrence. Ribociclib: 400 mg daily 21 days on/7 days off for 3 years At 5 years: absolute improvement in invasive disease free survival (survival without disease) was 4.5% in patients receiving ribociclib (81% in endocrine therapy alone versus 85.5% in ribociclib end
In this video, I discuss ribociclib and abemaciclib in early stage HR /HER2- breast cancer. Both are CDK 4/6 inhibitors which interfere with the cell cycle and are used in combination with endocrine therapy to decrease the risk of recurrence. Ribociclib: 400 mg daily 21 days on/7 days off for 3 years At 5 years: absolute improvement in invasive disease free survival (survival without disease) was 4.5% in patients receiving ribociclib (81% in endocrine therapy alone versus 85.5% in ribociclib end
Facebook5 months ago
Top videos
KISQALI TV Spot, 'Long Live'
KISQALI TV Spot, 'Long Live'
iSpot.tv
Dec 6, 2022
Breast cancer treatment: Drug Kisqali approval expanded for earlier stage disease
1:31
Breast cancer treatment: Drug Kisqali approval expanded for earlier stage disease
NBC NewsMustafa Fattah,Marina
Sep 17, 2024
FDA expands use of breast cancer drug Kisqali
FDA expands use of breast cancer drug Kisqali
ny1.com
Oct 11, 2024
Ribociclib Side Effects
Let me know your symptoms/side effects of the ribociclib. Also how your feeling since taking it. #breastcancer #cancertreatments #lifeaftercancer #cancersurvivor #breastcancersurvivor
2:13
Let me know your symptoms/side effects of the ribociclib. Also how your feeling since taking it. #breastcancer #cancertreatments #lifeaftercancer #cancersurvivor #breastcancersurvivor
TikTokjadesjourney90
832 views2 months ago
⭐️ Update on longer outcomes with ribociclib (Kisqali) and abemaciclib (Verzenio) in hormone receptor positive/HER2 negative early stage breast cancer. ⭐️ These are CDK 4/6 inhibitors given in conjunction with endocrine therapy to reduce risk of recurrence. (CDK 4/6 inhibitors are standard of care in the treatment HR metastatic breast cancer as well). In early stage BC, abemaciclib is taken for 2 years and ribociclib for 3 years. In this video, I share with you recent updates (they are positive!
4:04
⭐️ Update on longer outcomes with ribociclib (Kisqali) and abemaciclib (Verzenio) in hormone receptor positive/HER2 negative early stage breast cancer. ⭐️ These are CDK 4/6 inhibitors given in conjunction with endocrine therapy to reduce risk of recurrence. (CDK 4/6 inhibitors are standard of care in the treatment HR metastatic breast cancer as well). In early stage BC, abemaciclib is taken for 2 years and ribociclib for 3 years. In this video, I share with you recent updates (they are positive!
FacebookEleonora Teplinsky, MD
20.5K views7 months ago
Ribociclib || What Are The Side Effects?? || Everything You Need To know || Dr. Bharat Patodiya
11:02
Ribociclib || What Are The Side Effects?? || Everything You Need To know || Dr. Bharat Patodiya
YouTubePi Cancer Care
8.7K viewsApr 22, 2022
KISQALI TV Spot, 'Long Live'
KISQALI TV Spot, 'Long Live'
Dec 6, 2022
iSpot.tv
Breast cancer treatment: Drug Kisqali approval expanded for earlier stage disease
1:31
Breast cancer treatment: Drug Kisqali approval expanded for earlier stage disease
Sep 17, 2024
NBC NewsMustafa Fattah,Marina Kopf,Kathy Park
FDA expands use of breast cancer drug Kisqali
FDA expands use of breast cancer drug Kisqali
Oct 11, 2024
ny1.com
KISQALI TV Spot, 'Invest in Your Future'
1:00
KISQALI TV Spot, 'Invest in Your Future'
Apr 26, 2022
iSpot.tv
KISQALI TV Spot, 'We Are the Thrivers'
1:30
KISQALI TV Spot, 'We Are the Thrivers'
Jan 5, 2020
iSpot.tv
Novartis Kisqali(R) 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broadest early breast cancer patient population
Novartis Kisqali(R) 5-year NATALEE data demonstrate 28% reduction in risk of recurrence in the broadest early breast cancer patient population
7 months ago
marketscreener.com
Drug found to reduce risk of breast cancer coming back
1:27
Drug found to reduce risk of breast cancer coming back
Jun 2, 2023
ABC13 HoustonSony Salzman
1:15
KISQALI TV Spot, 'More Time'
Feb 23, 2021
iSpot.tv
KISQALI TV Spot, 'Time: Life's Most Precious Commodity'
Nov 8, 2022
iSpot.tv
7:18
Kisqali (Ribociclib) for Breast Cancer: Uses, Side Effects, and What to Expect
20.3K viewsJul 7, 2024
YouTubeYerbba – Breast Cancer
2:44
MSN
Sep 18, 2024
MSNTODAY
KISQALI TV Spot, 'The First Generation of Patients'
Aug 16, 2022
iSpot.tv
12:58
The Science Behind Kisqali: Understanding how this Targeted Therapy Works to Treat Cancer
2.6K viewsSep 21, 2023
YouTubeInevid
13:52
My Targeted Therapy Experience - Ribociclib/Kisqali for Metastatic Breast Cancer
20.5K viewsFeb 17, 2022
YouTubeSamantha Lynn
Story from Novartis Kisqali: Younger women diagnosed with breast cancer focus on the future
5 months ago
cincinnati.com
5:33
#kisqalitreatment #kisqali #breastcancer #fypgirls #pinksisters
197 views4 months ago
TikTokintravelgirl
4:06
FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer ESMO 2024
4.3K viewsSep 18, 2024
YouTubeOncologyTube
4:48
FDA Approves Ribociclib (Kisqali) for Stage 2-3 HR+/HER2- Breast Cancer at Higher Risk of Recurrence
1.9K viewsSep 18, 2024
YouTubeEleonora Teplinsky, MD
2:00
How does Kisqali (Ribociclib) Cancer Treatment Work?
4.3K views1 year ago
YouTubeDr. Rob Swanda
14:50
Stage 4 Cancer: Starting Zometa and Kisqali (ribociclib)
17.2K viewsOct 1, 2023
YouTubeDee Doherty
0:23
Kisqali 200mg |Ribociclib Tablet #ribociclib #kisqali#cancer#breastcancer #medicine #dr-anjum#shorts
2K viewsJul 14, 2024
YouTubeMedical Era
4:45
Dramatic OS Boost With Kisqali in Young Breast Ca Patients - Medpage Today
1.5K viewsJun 11, 2019
YouTubeMedPage Today
KISQALI TV Spot, 'Anna'
4 months ago
iSpot.tv
KISQALI TV Spot, 'Two Things'
Apr 8, 2024
iSpot.tv
KISQALI TV Spot, 'Have Both'
Sep 11, 2023
iSpot.tv
0:14
Kisqali: A Game-Changer for Early Breast Cancer?
626 viewsSep 20, 2024
YouTubePharma Quotient
18:42
Stage 4 Cancer UPDATE: Kisqali (Ribociclib), Letrozole, Zoladex and Zometa
11.7K viewsFeb 25, 2024
YouTubeDee Doherty
KISQALI TV Spot, 'Jordan'
Oct 23, 2024
iSpot.tv
1:12
In response to last night’s announcement, we asked Medical Oncologist Dr Belinda Yeo what it means for people living with early breast cancer to have Kisqali (ribociclib) listed on the Pharmaceutical Benefits Scheme (PBS). You can read more about the announcement at https://ow.ly/X6sR50WiV55 #breastcancerawareness #cancertreatment #earlybreastcancer #PBSlisting | Breast Cancer Network Australia
34.6K views10 months ago
FacebookBreast Cancer Network Australia
See more